1. Home
  2. BLCO vs CRUS Comparison

BLCO vs CRUS Comparison

Compare BLCO & CRUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BLCO
  • CRUS
  • Stock Information
  • Founded
  • BLCO 1853
  • CRUS 1984
  • Country
  • BLCO Canada
  • CRUS United States
  • Employees
  • BLCO N/A
  • CRUS N/A
  • Industry
  • BLCO Ophthalmic Goods
  • CRUS Semiconductors
  • Sector
  • BLCO Health Care
  • CRUS Technology
  • Exchange
  • BLCO Nasdaq
  • CRUS Nasdaq
  • Market Cap
  • BLCO 5.2B
  • CRUS 5.9B
  • IPO Year
  • BLCO 2022
  • CRUS 1989
  • Fundamental
  • Price
  • BLCO $14.97
  • CRUS $126.33
  • Analyst Decision
  • BLCO Hold
  • CRUS Strong Buy
  • Analyst Count
  • BLCO 12
  • CRUS 4
  • Target Price
  • BLCO $15.91
  • CRUS $123.75
  • AVG Volume (30 Days)
  • BLCO 490.9K
  • CRUS 464.6K
  • Earning Date
  • BLCO 10-29-2025
  • CRUS 11-04-2025
  • Dividend Yield
  • BLCO N/A
  • CRUS N/A
  • EPS Growth
  • BLCO N/A
  • CRUS 18.67
  • EPS
  • BLCO N/A
  • CRUS 6.40
  • Revenue
  • BLCO $4,891,000,000.00
  • CRUS $1,929,323,000.00
  • Revenue This Year
  • BLCO $8.29
  • CRUS N/A
  • Revenue Next Year
  • BLCO $5.82
  • CRUS $5.49
  • P/E Ratio
  • BLCO N/A
  • CRUS $19.70
  • Revenue Growth
  • BLCO 8.81
  • CRUS 4.52
  • 52 Week Low
  • BLCO $10.45
  • CRUS $75.83
  • 52 Week High
  • BLCO $21.08
  • CRUS $129.56
  • Technical
  • Relative Strength Index (RSI)
  • BLCO 53.23
  • CRUS 58.08
  • Support Level
  • BLCO $14.67
  • CRUS $116.22
  • Resistance Level
  • BLCO $15.31
  • CRUS $129.54
  • Average True Range (ATR)
  • BLCO 0.45
  • CRUS 3.52
  • MACD
  • BLCO -0.00
  • CRUS -0.61
  • Stochastic Oscillator
  • BLCO 78.25
  • CRUS 75.90

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

About CRUS Cirrus Logic Inc.

Cirrus Logic Inc is a provider of integrated circuits for audio and voice signal processing applications. The firm's products are organized into two streams: portable audio products, and HPMS Products. These products include aAmplifiers, codecs, smart codecs, analog-to-digital converters, digital-to-analog converters and standalone digital signal processors, Camera controllers, haptics and sensing solutions, and battery and power ICs. Roughly half of the firm's revenue is generated in China, with the rest coming from the United States, Europe, South Korea, and countries across the world.

Share on Social Networks: